Clinical trial
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV…
NCT00005810 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00005810 |
|---|---|
| Title | Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy |
| Official title | A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, carboplatin, docetaxel, estramustine phosphate sodium |
| Enrollment | 40 |
| Start date | Mar 1, 2000 |
| Primary completion | Dec 1, 2003 |
| Completion | Jun 1, 2006 |
| First posted | Apr 19, 2004 |
| Last update posted | Jul 14, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: